Diyong Xu is a Principal on the Private Equity team at OrbiMed, covering venture capital investments in biotech, medical device and diagnostics companies. Diyong has been a board observer for Terns. He was previously a board observer for Arcutis, Imara, NextCure, Passage Bio, Repare and SpringWorks.
Prior to joining OrbiMed, Diyong worked for L...
Roles at Q32 Bio